Pulmobiotics: Funding, Investors & Team (Sep 2026)
Pulmobiotics SL is a a spin off company from the Centre for Genomic Regulation (Barcelona - Spain) founded by experienced entrepreneurs and funded by invivo Ventures. Using a proprietary microbial engineering and synthetic biology toolbox our founders have created a platform based on attenuated lung bacteria that is able to expose antigens or deliver therapeutic agents in the lung in a controlled, local and continuous manner. Pulmobiotics SL will use this technology to discover and develop novel treatments and vaccines for respiratory diseases, which are among the most common causes of severe illness and death worldwide.
Pulmobiotics has raised $4.0M across 2 funding rounds on record, the most recent an undisclosed round of $2.0M announced in Dec 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Pulmobiotics Company Profile and Key Stats
Latest funding round on record: Dec 2022.
Pulmobiotics Funding Rounds
Pulmobiotics raised $2.0M in an undisclosed round announced in Apr 2020.
2.7 years later, an undisclosed round of $2.0M was announced in Dec 2022.
Pulmobiotics Founders and Leadership Team
No contact details are on record for this team yet.
Pulmobiotics Funding Compared to Other Biotechnology Startups
Pulmobiotics' latest round of $2.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Pulmobiotics in Biotechnology and Barcelona
Companies Similar to Pulmobiotics
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…
Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological…
Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic…
IMPETUX develops and markets patented technology to characterise the mechanical properties of living tissues…
Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience. These drugs…
Modern medicine fails because it studies life in static environments. 60Nd revolutionizes the field with…
Devicare designs point-of-care medical devices that monitor, diagnose and treat chronic diseases. The…
Universal Diagnostics S.A. (UDX) is a company in Spain that specializes in in-vitro diagnostics. Their focus…
Phyture Biotech originated as a spin-off of the Faculty of Pharmacy at the University of Barcelona, founded…
Polimerbio offers sanitary product design and development based on biocompatible polymers, particularly…
Overture Life is a biotechnology company that specializes in developing automated technologies for assisted…
In order to cure diseases with unmet medical requirements, ARTHEx Biotech, a biotech business that was spun…
Pulmobiotics Funding FAQs
What does Pulmobiotics do?
Pulmobiotics SL is a a spin off company from the Centre for Genomic Regulation (Barcelona - Spain) founded by experienced entrepreneurs and funded by invivo Ventures. Using a proprietary microbial engineering and synthetic biology toolbox our founders have created a platform based on attenuated lung bacteria that is able to expose antigens or deliver therapeutic agents in the lung in a controlled, local and continuous manner. Pulmobiotics SL will use this technology to discover and develop novel treatments and vaccines for respiratory diseases, which are among the most common causes of severe illness and death worldwide.
How much funding has Pulmobiotics raised?
Pulmobiotics has raised $4.0M across 2 rounds on record. The most recent is an undisclosed round of $2.0M announced in Dec 2022.
When did Pulmobiotics last raise funding?
Pulmobiotics' most recent funding round on record is an undisclosed round of $2.0M, announced in Dec 2022.
Who founded Pulmobiotics?
FundedIQ lists Lluis Serrano (Founder) at Pulmobiotics.
Who is the CEO of Pulmobiotics?
Claudio Santos is listed as CEO at Pulmobiotics.
Where is Pulmobiotics headquartered?
Pulmobiotics is based in Barcelona, Catalonia, Spain.
How many employees does Pulmobiotics have?
Pulmobiotics is in the 1-10 employee band.
How does Pulmobiotics' funding compare to other Biotechnology startups?
Pulmobiotics' latest round of $2.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Pulmobiotics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pulmobiotics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.